1 / 17

Molecular pathogenesis of subarachnoid haemorrhage

Molecular pathogenesis of subarachnoid haemorrhage. Baiping Zhang, Kaare Gugleholm, Lorna B. Day, Shu Ye, Roy O. Weller, Ian N.M. Day 5 November 2002. Pathogenesis and the stages involved in the formation of saccular aneurysm Cellular and molecular architecture of the vessel wall

tanaya
Download Presentation

Molecular pathogenesis of subarachnoid haemorrhage

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Molecular pathogenesis of subarachnoid haemorrhage Baiping Zhang, Kaare Gugleholm, Lorna B. Day, Shu Ye, Roy O. Weller, Ian N.M. Day 5 November 2002

  2. Pathogenesis and the stages involved in the formation of saccular aneurysm • Cellular and molecular architecture of the vessel wall • Molecular pathology • PKD1 gene and polycystin • COL3A1 and type III collagen • Fibrillin-1 • Collagen IV and other basement membrane constituents • Alpha1-Antitrypsin (protease inhibitor) • Future focus

  3. Subarachnoid haemorrhage (SAH) • Condition caused by the escape of blood from a cerebral artery into the subarachnoid space along the surface of the brain. http://instruct.uwo.ca/anatomy/530/SagSin.gif

  4. Mortality of diagnosed cases is about 40% within the first 30 days • Less then 25% have a good functional outcome and the disease has dramatic impact on the lives of carers and relatives. Pritchard, Foulkes, Lang, & Neil-Dwyer. 2001

  5. Schematic overview of contributory factors to subarachnoid haemorrhage B. Zhang et al./ The International Journal of Biochemistry & Cell Biology 35 (2003) 1341-1360

  6. Commonest sites for Saccular Aneurysms B. Zhang et al./ The International Journal of Biochemistry & Cell Biology 35 (2003) 1341-1360

  7. B. Zhang et al./ The International Journal of Biochemistry & Cell Biology 35 (2003) 1341-1360

  8. Etiology involved in the formation of saccular aneurysms • Majority of aneurysms occur between the ages of 40 and 70 • Ageing effects on the arteries • Increased incidence of saccular aneurysms in families with • Polycystic kidney disease • Fibromuscular dysplasia • Moyamoya disease • Marfan Syndrome • EDS type IV

  9. PKD1 gene and polycystin • Adult polycystic kidney disease is an autosomal dominant disorder in which renal cysts form, leading to progressive loss of glomerular filtration and subsequently to renal failure and end-stage renal disease. • PKD1 gene causing (PKD) • Encodes for a protein named polycystin • Polycystin - participates in protein-protein and protein-carbohydrate interactions in the extracellular matrix adpkd.cimr.cam.ac.uk/ buttons/pkd1_hs_350.gif

  10. COL3A1 and type III collagen • Ehlers-Danlos Syndrome Vascular Type • Arterial rupture risk • Thin transparent skin • Early bruising • Joint laxity • Ligament weakness • Bowel rupture • (EDS type IV) • Defective collagen III synthesis • Vascular expression on COL3A1

  11. Collagen IV and other basement membrane constituents • Collagen IV defects cause Alport’s syndrome. • Alports syndrome characterized sensorineural hearing loss and haematuria. • Its is therefore plausible new hypothesis that defects in the basement membrane as well as defects in the elastic and medial layer may predispose intracranial aneurysms

  12. Protease inhibitor (alpha1-Antitrypsin) • Most abundant and potent natural inhibitor of elastase. • Alpha1-Antitrypsin activity has been claimed to be reduced in both intracranial and abdominal aortic aneurysm.

  13. Future focus

  14. Fibrillin-1 and FBN1 • Marfan syndrome is an autosomal dominant heritable disorder of connective tissue with prominent manifestations affecting the skeletal, ocular and cardiovascular systems. • Progressive dilation of the aortic root and aortic dissection and rupture are frequent, and mitral and aotic valve insufficiency may also occur early. • Caused by mutations in FBN1 gene encoding fibrilin-1 • Mutations of this gene also cause type I fibrillinopathies

More Related